Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

2 days ago 3

Noor Ul Ain Rehman

Tue, March 31, 2026 astatine 10:06 AM CDT 2 min read

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is 1 of the champion precocious maturation healthcare stocks to bargain now. Cantor Fitzgerald chopped the terms people connected Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to $31 from $35 connected March 13, reiterating an Overweight standing connected the shares and telling investors successful a probe enactment that it updated its exemplary aft the fiscal Q4 net report, which includes pruning estimates for some Syfovre and Empaveli.

Why Apellis Pharmaceuticals, Inc. (APLS) Skyrocketed On Monday

In its fiscal Q4 and afloat twelvemonth 2025 fiscal results, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) reported nett merchandise revenues of $689 cardinal for the afloat twelvemonth 2025, with SYFOVRE® (pegcetacoplan injection) afloat twelvemonth 2025 nett merchandise gross of $587 cardinal and EMPAVELI® (pegcetacoplan) afloat twelvemonth 2025 nett merchandise gross of $102 million. It besides stated that the regulatory submission for SYFOVRE prefilled syringe is planned for the archetypal fractional of 2026. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) has currency and currency equivalents of $466 cardinal arsenic of December 31, 2025, with projected revenues, cash, and currency equivalents anticipated to beryllium capable to money operations to profitability.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is simply a commercial-stage biopharmaceutical institution that discovers, develops, and commercializes caller therapeutic compounds for treating diseases with unmet needs. Its merchandise portfolio chiefly includes EMPAVELI and SYFOVRE. SYFOVRE treats geographic atrophy secondary to age-related macular degeneration (GA), portion EMPAVELI treats paroxysmal nocturnal hemoglobinuria (PNH).

While we admit the imaginable of APLS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article